Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successes
Author:
Affiliation:
1. The Ann Hayes Consultancy Buntingford Hertfordshire UK
2. Imperial College London Hammersmith Hospital London UK
Publisher
Wiley
Subject
General Pharmacology, Toxicology and Pharmaceutics,Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.510
Reference7 articles.
1. The European College of Neuropsychopharmacology (ECNP) Medicines Chest Initiative: Rationale and Promise
2. THuNDRous news for human dopamine researchers: A selective dopamine D1 receptor antagonist will soon be available for clinical research
3. Pioneering government-sponsored drug repositioning collaborations: progress and learning
4. NCATS launches drug repurposing program
5. Drug repurposing: progress, challenges and recommendations
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Repurposing of Drugs for Cardiometabolic Disorders: An Out and Out Cumulation;Hormone and Metabolic Research;2023-01
2. Drug repurposing: a systematic review on root causes, barriers and facilitators;BMC Health Services Research;2022-07-29
3. Clinical pharmacology: Current innovations and future challenges;Fundamental & Clinical Pharmacology;2022-01-26
4. Human Genomics and Drug Development;Cold Spring Harbor Perspectives in Medicine;2021-10-14
5. Drug Repurposing for Rare Diseases;Trends in Pharmacological Sciences;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3